Biomarker Detection
Antibodies, ELISA kits, proteins, standards and controls for ovarian markers.
Explore research-use products for ovarian tumor biology, epithelial ovarian cancer, fallopian tube cancer models, primary peritoneal cancer research, BRCA/HRD biology, TP53-driven tumor progression, CA-125/MUC16, HE4, PAX8, WT1, angiogenesis, ascites, immune profiling, peritoneal spread and experimental drug-response workflows.
Build ovary tumor research workflows using antibodies, ELISA kits, recombinant proteins, molecular biology tools, cell culture reagents and functional assay systems.
Primary antibodies for CA-125/MUC16, HE4, PAX8, WT1, TP53, Ki-67, EPCAM, BRCA1, BRCA2, PD-L1, CD8, VEGF and subtype-associated markers.
View antibodiesKits and assays for ovarian tumor biomarkers, cytokines, chemokines, angiogenesis markers, growth factors and soluble immune mediators.
View ELISA kitsRecombinant proteins, calibrators and standards for assay development, antibody validation, pathway stimulation and experimental controls.
View proteinsMolecular tools for BRCA/HRD research, TP53 studies, epithelial marker profiling, gene expression, DNA damage response and ovarian subtype analysis.
View molecular toolsMedia, supplements, matrices, transfection reagents and 3D culture tools for ovarian tumor cell models, spheroids, ascites-like models and co-culture systems.
View culture toolsATP, cytotoxicity, apoptosis, proliferation, DNA damage, migration, invasion, oxidative stress and spheroid-response assay systems.
View assay toolsOvarian cancer research often studies lineage identity, DNA repair, proliferation, immune infiltration, angiogenesis, ascites biology and peritoneal spread.
CA-125 is commonly associated with MUC16 and widely studied in ovarian cancer biomarker and monitoring research.
HE4 is studied in ovarian cancer biomarker assays and epithelial tumor research workflows.
PAX8 is commonly used in ovarian, fallopian tube and related Müllerian tumor lineage studies.
WT1 is frequently studied in serous ovarian carcinoma classification and tissue-marker workflows.
Choose a workflow and get product groups matched to ovarian tumor research needs.
Recommended product groups: primary antibodies, secondary antibodies, FFPE-compatible markers, antigen retrieval reagents, CA-125/MUC16, PAX8, WT1, TP53, Ki-67, ER, PR, PD-L1, CD8, VEGF and stromal markers.
Browse tissue research productsUse ovary tumor research products across biomarker discovery, assay validation, molecular pathway analysis, immune profiling, subtype research and experimental models.
Study TP53, BRCA/HRD, WT1, PAX8, genomic instability and peritoneal spread.
Analyze BRCA1, BRCA2, PARP biology, DNA damage response and repair-deficient models.
Study tumor-cell survival in fluid, multicellular aggregates, adhesion and anoikis resistance.
Profile PD-1, PD-L1, CD8, macrophage markers, cytokines, chemokines and immune escape.
Measure VEGF, vascular markers, hypoxia response, permeability and ascites-related signaling.
Measure viability, apoptosis, DNA damage, cytotoxicity, proliferation and resistance mechanisms.
Product selection should match the biological target, ovarian tumor subtype, sample type, assay format and validation requirements.
Examples: CA-125 detection, BRCA/HRD biology, TP53 mutation research, ascites models, immune profiling or drug response.
Review compatibility with FFPE tissue, frozen tissue, serum, plasma, ascites fluid, cell lysates or cultured cells.
Confirm suitability for IHC, WB, IF, ELISA, qPCR, flow cytometry, cell culture or functional assays.
Include positive controls, negative controls, calibrators, reference samples and reproducibility checks.
Explore research-use tools for ovarian tumor biomarkers, epithelial ovarian cancer biology, BRCA/HRD research, tissue studies, immune profiling, ascites models and experimental drug-response workflows.
Clear answers to common product-selection and ovarian tumor workflow questions.
Ovarian cancer research products are laboratory-use reagents and assay tools used to study ovarian tumor biology, epithelial ovarian cancer biomarkers, DNA repair, tumor microenvironment, peritoneal spread, ascites and drug response.
Frequently studied biomarkers include CA-125/MUC16, HE4, PAX8, WT1, TP53, Ki-67, BRCA1, BRCA2, PD-L1, CD8, VEGF, EPCAM, ER and PR.
Tissue-based studies commonly use primary antibodies, secondary antibodies, IHC reagents, FFPE-compatible controls, lineage markers, proliferation markers, immune markers and stromal markers.
No. Products described on this page are presented for research use only unless an individual product page clearly states otherwise.
Authoritative sources supporting ovarian cancer biology, biomarkers and research context.